Literature DB >> 23759469

Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease.

Robert K McNamara1, Ronald Jandacek, Patrick Tso, Yogesh Dwivedi, Xinguo Ren, Ghanshyam N Pandey.   

Abstract

BACKGROUND: A growing body of evidence suggests that deficits in long-chain omega-3 (LCn-3) fatty acids may contribute to major depressive disorder (MDD) and principal causes of excess mortality including suicide and cardiovascular disease. In the present study we compared concentrations of docosahexaenoic acid (DHA, 22:6n-3), the principal LCn-3 fatty acid in brain, in the postmortem prefrontal cortex (BA10) of adult depressed suicide victims and controls with and/or without cardiovascular disease.
METHODS: DHA concentrations (μmol/g) in the prefrontal cortex (PFC, BA10) of adult male and female suicide victims (n = 20) and controls with (n = 8) or without (n = 12) cardiovascular disease were determined by gas chromatography.
RESULTS: There was a non-significant trend for lower DHA concentrations in suicide victims compared with all controls (-10%, p = 0.06, d = 0.5). Significantly lower DHA concentrations were observed in suicide victims compared with controls without cardiovascular disease (-14%, p = 0.03, d = 0.7) but not controls with cardiovascular disease (-4%, p = 0.71, d = 0.1). There was a non-significant trend for lower DHA concentrations in controls with cardiovascular disease compared with controls without cardiovascular disease (-11%, p = 0.1, d = 0.6).
CONCLUSIONS: Adult depressed suicide victims exhibit lower postmortem PFC DHA concentrations compared with controls without cardiovascular disease. These data add to a growing body of evidence implicating DHA deficits in the pathophysiology of MDD, suicide, and cardiovascular disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; Docosahexaenoic acid (DHA); Omega-3 fatty acid; Postmortem brain; Prefrontal cortex; Suicide

Mesh:

Substances:

Year:  2013        PMID: 23759469      PMCID: PMC3710518          DOI: 10.1016/j.jpsychires.2013.05.007

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  33 in total

Review 1.  Brain phospholipases A2: a perspective on the history.

Authors:  Akhlaq A Farooqui; Lloyd A Horrocks
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-09       Impact factor: 4.006

2.  Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Xinguo Ren; Jawed Fareed; Debra A Hoppensteadt; Rosalinda C Roberts; Robert R Conley; Yogesh Dwivedi
Journal:  J Psychiatr Res       Date:  2011-09-08       Impact factor: 4.791

3.  Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  J Affect Disord       Date:  2010-04-21       Impact factor: 4.839

4.  Fatty acid composition in postmortem brains of people who completed suicide.

Authors:  Aleksandra Lalovic; Emile Levy; Lilian Canetti; Adolfo Sequeira; Alain Montoudis; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

5.  Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects.

Authors:  Robert K McNamara; Jessica Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  J Psychiatr Res       Date:  2008-11-04       Impact factor: 4.791

6.  Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes.

Authors:  Nancy Frasure-Smith; François Lespérance; Pierre Julien
Journal:  Biol Psychiatry       Date:  2004-05-01       Impact factor: 13.382

7.  Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.

Authors:  William S Harris; Scott A Sands; Sheryl L Windsor; Hakim A Ali; Tracy L Stevens; Anthony Magalski; Charles B Porter; A Michael Borkon
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

8.  Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study.

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi; Hooriyah S Rizavi; Xinguo Ren; Robert R Conley
Journal:  Arch Gen Psychiatry       Date:  2004-07

9.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.

Authors:  Pao-Yen Lin; Kuan-Pin Su
Journal:  J Clin Psychiatry       Date:  2007-07       Impact factor: 4.384

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more
  14 in total

1.  Lack of association of SNPs from the FADS1-FADS2 gene cluster with major depression or suicidal behavior.

Authors:  M Elizabeth Sublette; Concepcion Vaquero; Enrique Baca-Garcia; Gabriela Pachano; Yung-Yu Huang; Maria A Oquendo; J John Mann
Journal:  Psychiatr Genet       Date:  2016-04       Impact factor: 2.458

Review 2.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

3.  Adult emotionality and neural plasticity as a function of adolescent nutrient supplementation in male rats.

Authors:  Nora McCall; Darshini Mahadevia; Jennifer A Corriveau; Melissa J Glenn
Journal:  Pharmacol Biochem Behav       Date:  2015-03-14       Impact factor: 3.533

4.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

Review 5.  Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.

Authors:  Najam A Sharif
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

6.  Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

Authors:  Robert K McNamara; Jennifer Strimpfel; Ronald Jandacek; Therese Rider; Patrick Tso; Jeffrey A Welge; Jeffrey R Strawn; Melissa P Delbello
Journal:  PharmaNutrition       Date:  2014-04-01

7.  Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Authors:  Robert K McNamara; Therese Rider; Ronald Jandacek; Patrick Tso
Journal:  Psychiatry Res       Date:  2014-01-02       Impact factor: 3.222

8.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

9.  Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.

Authors:  Jessica A Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

10.  Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Wen-Jang Chu; Wade A Weber; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello
Journal:  Nutr Neurosci       Date:  2016-03-02       Impact factor: 4.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.